Tocqueville Asset Management’s Tandem Diabetes Care TNDM Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-4,500
| Closed | -$215K | – | 623 |
|
2022
Q3 | $215K | Hold |
4,500
| – | – | ﹤0.01% | 559 |
|
2022
Q2 | $266K | Sell |
4,500
-100
| -2% | -$5.91K | ﹤0.01% | 593 |
|
2022
Q1 | $535K | Hold |
4,600
| – | – | 0.01% | 504 |
|
2021
Q4 | $692K | Hold |
4,600
| – | – | 0.01% | 508 |
|
2021
Q3 | $549K | Hold |
4,600
| – | – | 0.01% | 518 |
|
2021
Q2 | $448K | Buy |
4,600
+100
| +2% | +$9.74K | 0.01% | 577 |
|
2021
Q1 | $397K | Hold |
4,500
| – | – | 0.01% | 589 |
|
2020
Q4 | $431K | Hold |
4,500
| – | – | 0.01% | 564 |
|
2020
Q3 | $511K | Sell |
4,500
-700
| -13% | -$79.5K | 0.01% | 486 |
|
2020
Q2 | $514K | Sell |
5,200
-3,050
| -37% | -$301K | 0.01% | 480 |
|
2020
Q1 | $531K | Sell |
8,250
-1,350
| -14% | -$86.9K | 0.01% | 446 |
|
2019
Q4 | $572K | Buy |
9,600
+1,350
| +16% | +$80.4K | 0.01% | 529 |
|
2019
Q3 | $487K | Buy |
8,250
+4,200
| +104% | +$248K | 0.01% | 567 |
|
2019
Q2 | $261K | Sell |
4,050
-1,500
| -27% | -$96.7K | ﹤0.01% | 705 |
|
2019
Q1 | $352K | Sell |
5,550
-8,000
| -59% | -$507K | ﹤0.01% | 650 |
|
2018
Q4 | $514K | Sell |
13,550
-500
| -4% | -$19K | 0.01% | 550 |
|
2018
Q3 | $602K | Sell |
14,050
-10,300
| -42% | -$441K | 0.01% | 584 |
|
2018
Q2 | $536K | Sell |
24,350
-15,450
| -39% | -$340K | 0.01% | 593 |
|
2018
Q1 | $197K | Buy |
+39,800
| New | +$197K | ﹤0.01% | 791 |
|
2017
Q4 | – | Sell |
-1,700
| Closed | -$12K | – | 829 |
|
2017
Q3 | $12K | Sell |
1,700
-1,240
| -42% | -$8.75K | ﹤0.01% | 804 |
|
2017
Q2 | $24K | Buy |
2,940
+200
| +7% | +$1.63K | ﹤0.01% | 781 |
|
2017
Q1 | $33K | Buy |
2,740
+325
| +13% | +$3.91K | ﹤0.01% | 792 |
|
2016
Q4 | $52K | Sell |
2,415
-7,725
| -76% | -$166K | ﹤0.01% | 791 |
|
2016
Q3 | $777K | Buy |
10,140
+300
| +3% | +$23K | 0.01% | 546 |
|
2016
Q2 | $742K | Buy |
9,840
+100
| +1% | +$7.54K | 0.01% | 553 |
|
2016
Q1 | $848K | Buy |
9,740
+1,285
| +15% | +$112K | 0.01% | 528 |
|
2015
Q4 | $999K | Buy |
8,455
+1,750
| +26% | +$207K | 0.01% | 547 |
|
2015
Q3 | $591K | Buy |
+6,705
| New | +$591K | 0.01% | 660 |
|